Paul R. Wainman is Director at IMMUCELL CORP /DE/ (ICCC). They have made 6 open-market trades across 1 company since 2014, most recently 2019-03-11.
CIK 0001603581
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $9K since 2014, never a sale. Across 6 scored buys the stock is up 0.0% at ninety days, and 0.3 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ICCC | 6,269 | $67K |
Shares reported on the most recent Form 4, priced at the 2019-03-13 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 0% | 0% |
| Avg Move | +4.2% | +0.0% | +0.0% |
| Alpha | +10.0% | -0.3% | -0.3% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICCC | BUY | 2015-09-14 | 2015-09-16 | $6.80 | $1K | +4.2% | +0.0% | +0.0% |
| ICCC | BUY | 2014-11-13 | 2014-11-17 | $4.80 | $2K | +4.2% | +0.0% | +0.0% |
| ICCC | BUY | 2014-09-16 | 2014-09-17 | $4.50 | $1K | +4.2% | +0.0% | +0.0% |
| ICCC | BUY | 2014-08-19 | 2014-08-22 | $4.50 | $900 | +4.2% | +0.0% | +0.0% |
| ICCC | BUY | 2014-06-26 | 2014-06-30 | $4.35 | $1K | +4.2% | +0.0% | +0.0% |
| ICCC | BUY | 2014-06-11 | 2014-06-13 | $4.10 | $3K | +4.2% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.